Healthcare Industry News: Royal Philips
News Release - March 13, 2007
Philips Introduces Transport Monitor and on-Screen Protocol Compliance ApplicationIndustry Leader in Patient Monitoring Unveils Technology to Help Clinicians Combat Severe Sepsis
ANDOVER, Mass.--(HSMN NewsFeed)--Royal Philips Electronics (NYSE: PHG; AEX: PHI) announced today the introduction of Philips ProtocolWatch, an application available on Philips IntelliVue patient monitors that applies patient monitoring data to evidence-based care protocols. Philips also released the IntelliVue MP5, a compact, full-featured patient monitor for in-hospital patient transport.
A new development in clinical decision support at the bedside, ProtocolWatch is the first application to deliver customer-specific care protocols on the patient monitor screen. ProtocolWatch responsively uses monitoring measurements to offer relevant screening and treatment information from evidence-based care guidelines.
Focus on clarity and clinical decision support
The new offerings from Philips continue the company's effort to provide better means of summarizing and delivering patient monitoring information. David Russell, Philips Medical Systems' vice president for marketing, points out that physicians have overwhelming amounts of raw data to deal with. "Medical technology can provide endless numbers of data points. But beyond merely providing that accumulation of data, at Philips we're designing clinical decision support systems to provide clinicians a clearer picture of what's happening with a patient, turning data into clear, pertinent information and even providing guidance through clinical protocols," says Russell.
ProtocolWatch streamlines the process of checking a patient's monitoring data against evidence-based care guidelines. It allows hospitals to use their IntelliVue patient monitors to implement care protocols, helping to elevate the standard of care and improve compliance with regulatory mandates.
Helping clinicians combat severe sepsis
Severe sepsis is a condition in which the body's immune response to an infection spirals out of control, leading to organ dysfunction and death. It is the leading cause of death in non-coronary intensive care units. According to a 2001 study, sepsis has a mortality rate of 30 to 50 percent and an average cost per case of about $22,000 (Angus, DC et al., Crit Care Med 2001; Jul29(7):1303-1310). Complicating efforts to improve care, the symptoms of sepsis can appear similar to other conditions, resulting in diagnoses that can come too late.
In its initial release, ProtocolWatch brings the care guidelines developed by the Surviving Sepsis Campaign (SSC) to the Philips IntelliVue patient monitoring platform. The SSC protocol defines the physiological parameters that indicate the onset of severe sepsis. Since ProtocolWatch is built into the patient monitor, it can use the patient's vital signs to help clinicians screen for this deadly condition.
Once one of the parameters that act as an early warning sign for sepsis reaches the limits defined by the SSC protocol, a ProtocolWatch window appears on the monitor screen. This window prompts clinicians to check for other clinical signs of severe sepsis. If these signs are not present, ProtocolWatch resumes screening in the background.
If a clinician diagnoses a patient with severe sepsis, ProtocolWatch launches the Sepsis Resuscitation Bundle, displaying a checklist of interventions recommended by the SSC Sepsis Protocol. Since timing is critical when treating sepsis, ProtocolWatch also displays a timer. Once the Sepsis Resuscitation Bundle has ended, ProtocolWatch provides recommendations from the SSC Sepsis Management Bundle.
Decision support in motion
Philips IntelliVue MP5 provides a suite of clinical decision support tools common to IntelliVue monitors and makes them available in transport and telemetry settings. These include a variety of screen trends that visually present the story of a patient's monitoring data over time.
For example, Horizon Trends can display the past 30 minutes to 12 hours of measurements as a line graph related to a baseline, which can be a start or target value. The current measurement is a single prominent bar in relation to the baseline, with an arrow indicating the overall direction of the past 10 minutes of measurements. These and other screen trends can help clinicians rapidly identify significant changes in patient status, saving crucial time.
Rich in features, compact in design
The IntelliVue MP5 provides the functionality critical care clinicians know from higher-acuity IntelliVue monitors in a compact, lightweight, affordable unit ideal for transport and flexible care. The system features touchscreen operation, and an 8.4 inch screen displaying up to four waveforms. Its wired and wireless networking capability, sturdy housing and varied mounting options suit it to mobility.
In addition, with Telemetry as a Parameter (TAAP), the MP5 displays monitoring data collected by telemetry devices so that clinicians can read a patient's vital signs without having to go to the central station.
The MP5 connects to the IntelliVue Clinical Network for secure, reliable data transmission among patient monitors, telemetry, bedside devices, clinical information systems, and the central station. For patients in transit within the hospital, the networked MP5 allows clinicians at the central station to monitor parameters, alarms, and trends remotely.
About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a global leader in healthcare, lifestyle and technology, delivering products, services and solutions through the brand promise of "sense and simplicity." Headquartered in the Netherlands, Philips employs approximately 121,700 employees in more than 60 countries worldwide. With sales of USD 34 billion (EUR 27 billion) in 2006, the company is a market leader in medical diagnostic imaging and patient monitoring systems, energy efficient lighting solutions, personal care and home appliances, as well as consumer electronics. News from Philips is located at www.philips.com/newscenter.
Source: Royal Philips Electronics
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.